T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued to investors on Wednesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

TTOO stock opened at $0.23 on Wednesday. T2 Biosystems has a 12-month low of $0.22 and a 12-month high of $6.95. The stock’s 50 day simple moving average is $0.40 and its 200 day simple moving average is $1.88.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.